Mae, H., Fujimaru, T., Shimoyama, K., Kadota, N., Konishi, K., Itou, Y., . . . Nakayama, M. (2024). Association of serum sodium minus chloride level at initiation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and hyperkalemia in patients with CKD. Renal Replacement Therapy, 10(1), . https://doi.org/10.1186/s41100-024-00541-3
Chicago-referens (17:e uppl.)Mae, Haruki, Takuya Fujimaru, Koutarou Shimoyama, Nozomi Kadota, Kasumi Konishi, Yugo Itou, Masahiko Nagahama, Fumika Taki, och Masaaki Nakayama. "Association of Serum Sodium Minus Chloride Level at Initiation of Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Hyperkalemia in Patients with CKD." Renal Replacement Therapy 10, no. 1 (2024). https://doi.org/10.1186/s41100-024-00541-3.
MLA-referens (9:e uppl.)Mae, Haruki, et al. "Association of Serum Sodium Minus Chloride Level at Initiation of Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Hyperkalemia in Patients with CKD." Renal Replacement Therapy, vol. 10, no. 1, 2024, https://doi.org/10.1186/s41100-024-00541-3.
